Pyrilamine maleate salt
SIGMA/P5514
Synonym: Mepyramine maleate salt; N-
CAS Number: 59-33-6
Empirical Formula (Hill Notation): C17H23N3O · C4H4O4
Molecular Weight: 401.46
EC Number: 200-422-7
MDL Number: MFCD00069333
Linear Formula: C17H23N3O · C4H4O4
Product Type: Chemical
| form | powder |
| InChI | 1S/C17H23N3O.C4H4O4/c1-19 |
| InChI key | JXYWFNAQESKDNC-BTJKTKAUSA |
| originator | Watson |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C=C/C(O)=O.COc1ccc |
| Application: | Pyrilamine maleate salt has been used: • to treat Cassiopea sp. as H1 receptor antagonist • to intraperitoneally inject mice to prevent the release of endogenous histamine • in membrane binding assay to determine the Ki values and in the comparative inhibitory concentration (IC50) studies by whole-cell patch clamp technique |
| Biochem/physiol Actions: | Pyrilamine maleate is a H1 histamine receptor antagonist. Pyrilamine maleate induces sleep in vertebrates. In Cassiopea, it induces concentration dependent dormancy. |
| Features and Benefits: | This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Watson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25, 100 g in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352116 |


